Identifying risk factors for ALS through patient data analysis

RFA-TS-23-001: Assessment of ALS Risk Factors from ALS TDI's Ongoing Natural History Study (n = 784)

NIH-funded research Als Therapy Development Foundation · NIH-10913283

This study is looking at what might increase the risk of developing or worsening ALS by gathering information from people living with the condition, so we can better understand how health, lifestyle, and environment play a role.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAls Therapy Development Foundation NIH-funded
Lab location1 site (Watertown, United States)
Project IDNIH-10913283 on NIH RePORTER

What this research studies

This research investigates the risk factors associated with amyotrophic lateral sclerosis (ALS) by analyzing data collected from individuals living with the condition. The study involves a longitudinal approach, where participants provide extensive information about their health, lifestyle, and environmental factors through surveys administered every three months. Additionally, clinical data such as functional ratings, voice recordings, activity levels, and blood samples are collected to gain insights into the progression of ALS and its potential risk factors. The goal is to identify and confirm factors that may contribute to the development or progression of ALS.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with amyotrophic lateral sclerosis who are willing to participate in ongoing data collection and analysis.

Not a fit: Patients who do not have a diagnosis of ALS or are unable to provide the necessary data for analysis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of ALS risk factors, potentially guiding prevention strategies and personalized treatment options for patients.

How similar studies have performed: Previous research has shown success in identifying risk factors for ALS through similar longitudinal cohort studies, indicating that this approach is both valid and promising.

Where this research is happening

Watertown, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.